Gezielt nachschlagen
Suche
Suche startet nach einer kurzen Eingabepause.
20 angezeigte Treffer · Seite 1, keine Gesamtzahl für „pibrentasvir“
Suchtreffer
Begriffe & Kennungen
Atazanavir Viatris (previously Atazanavir Mylan) · 4.3 · Co-administration with glecaprevir/pibrentasvir fixed-dose combination (see section 4.5).
Eintrag öffnenAtazanavir Viatris (previously Atazanavir Mylan) · 4.5 · Co-administration of atazanavir with glecaprevir/pibrentasvir fixed-dose combination is contraindicated becaus
Eintrag öffnenEfavirenz/Emtricitabine/Tenofovir disoproxil Krka · 4.5 · 16 decrease plasma concentrations of glecaprevir and pibrentasvir, leading to reduced therapeutic effect. Co-a
Eintrag öffnenEfavirenz/Emtricitabine/Tenofovir disoproxil Krka · 4.5 · Glecaprevir/Pibrentasvir/Efavirenz Expected: Concomitant administration of Glecaprevir: ↓ glecaprevir/pibrenta
Eintrag öffnenEfavirenz/Emtricitabine/Tenofovir disoproxil Mylan · 4.5 · Glecaprevir/Pibrentasvir/Efavirenz Expected: Concomitant administration of Glecaprevir: ↓ glecaprevir/pibrenta
Eintrag öffnenEvotaz · 4.5 · * Effect of atazanavir and ritonavir on the first dose of glecaprevir and pibrentasvir is reported.
Eintrag öffnenEvotaz · 4.5 · pibrentasvir AUC: ↑64% (↑48% ↑82%) pibrentasvir Cmax: ↑29% (↑15% ↑45%) pibrentasvir Cmin: ↑129% (↑95% ↑168%)
Eintrag öffnenKaletra · 4.5 · 23 Glecaprevir/pibrentasvir Serum concentrations may be Concomitant administration of increased due to P-glyco
Eintrag öffnenKaletra · 4.5 · Lopinavir: ↔ Glecaprevir/pibrentasvir Serum concentrations may be Concomitant administration of increased due
Eintrag öffnenKaletra · 4.5 · Lopinavir: ↔ Glecaprevir/pibrentasvir Serum concentrations may be Concomitant administration of increased due
Eintrag öffnenLopinavir/Ritonavir Viatris (previously Ritonavir Mylan) · 4.5 · Lopinavir: ↔ Glecaprevir/pibrentasvir Serum concentrations may be Concomitant administration of increased due
Eintrag öffnenMaviret · 4.5 · Both glecaprevir and pibrentasvir inhibit the bile salt export pump (BSEP) in vitro.
Eintrag öffnenMaviret · 4.5 · Both glecaprevir and pibrentasvir inhibit the bile salt export pump (BSEP) in vitro.
Eintrag öffnenMaviret · 4.5 · Glecaprevir and pibrentasvir are inhibitors of P-glycoprotein (P-gp), breast cancer resistance protein (BCRP),
Eintrag öffnenMaviret · 4.5 · Glecaprevir and pibrentasvir are inhibitors of P-glycoprotein (P-gp), breast cancer resistance protein (BCRP),
Eintrag öffnenMaviret · 4.5 · Glecaprevir and pibrentasvir are substrates of the efflux transporters P-gp and/or BCRP. Glecaprevir is also a
Eintrag öffnenMaviret · 4.5 · Glecaprevir and pibrentasvir are substrates of the efflux transporters P-gp and/or BCRP. Glecaprevir is also a
Eintrag öffnenMaviret · 4.5 · Glecaprevir and pibrentasvir are weak inhibitors of cytochrome P450 (CYP) 3A and uridine glucuronosyltransfera
Eintrag öffnenMaviret · 4.5 · Glecaprevir and pibrentasvir are weak inhibitors of cytochrome P450 (CYP) 3A and uridine glucuronosyltransfera
Eintrag öffnenNorvir · 4.5 · Concomitant administration of glecaprevir/pibrentasvir and ritonavir is not recommended due to an increased ri
Eintrag öffnen